Skip to main content

Table 1 Prevalence of components of MetS at baseline and various lengths of follow-up [n(%)]

From: Prediction of the development of metabolic syndrome by the Markov model based on a longitudinal study in Dalian City

Follow-up years

 

Baseline

1

2

3

4

5

N

5881

5881

3518

2065

1346

825

Male

2476 (42.10)

2476 (42.10)

1356 (38.54)

637 (30.85)

388 (28.83)

279 (33.82)

Hypertension

740 (12.58)

901 (15.32)

576 (16.37)

361 (17.48)

296 (21.99)

221 (26.79)

Obesity

1795 (30.52)

1942 (33.02)

1135 (32.26)

653 (31.62)

431 (32.02)

293 (35.52)

Hyperglycemia

529 (9.00)

593 (10.08)

349 (9.92)

206 (9.98)

170 (12.63)

138 (16.73)

Dyslipidemia

1278 (21.73)

1316 (22.38)

782 (22.23)

431 (20.87)

276 (20.51)

189 (22.91)

MetS

249 (4.23)

431 (7.57)

256 (7.28)

158 (7.65)

136 (10.10)

110 (13.33)

  1. The interval between any two consecutive follow-up years was 1 year